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1. Introduction 
The administration of carcinogenic polycyclic 
hydrocarbons has been shown to enhance hepatic 
drug oxidation [ 1, 21. An increase takes place also 
in the skin [3-61, lungs and gastrointestin~ tract 
[7-91, kidneys [S] and placenta [ 1 O] . The oxida- 
tion step in detoxi~cation is followed in viva by 
conjugation. In separate studies an e~ancement of 
~ucuronide synthesis has been reported in the liver 
[ 1 1 - 1 S] and skin [ 161. The time courses of the 
responses have not, however, received much atten- 
tion. The present study was performed to clarify 
the responses of arylhydrocarbon hydroxylase 
(EC 1.14.1.1) and UDP glucuro]~yItransferase 
(EC 2.4.1.17) in the intestinal mucosa, liver and 
kidneys after an administration of 3,4-benzpyrene 
and 3-methylcholanthrene to rats. These two en- 
zymes have a close functional and topochemical 
relationship which suggests that their synthesis 
might have a common control mechanism. 
The rise of the UDP glucuronyhransferase activity 
was preceded with a much more pronounced rise of 
the arylhydrocarbon hydroxylase activity in all tis- 
sues studied. The induction of the hepatic hydroxyl- 
ase was significantly higher when the intraperitoneal 
administration route was used instead of the intra- 
gastric one. 
2. Methods 
Male Wistar rats (about 3 months old, total num- 
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ber 120) fed on comnlercia1 pellets ad I~b~t~~ were 
used. A single dose of 3,~benzpyrene (Sigma Chem- 
ical Co., St. Louis, MO.) or 3-methylcholanthrene 
(Koch-Light Laboratories Ltd, Colnbrook, England) 
was administered either intragastrically or intra- 
peritonealIy (100 mg/kg of body weight) as a sus- 
pension in olive oil (20 mg/ml). The control rats re- 
ceived an equal amount of olive oil. The animals 
were decapitated at 8 a.m. to eliminate the diurnal 
variation in drug metabolism [ 17). The small in- 
testine, liver and kidneys were excised and cooled 
in 0.25 M sucrose (0”). Ten cm long segments from 
duodenum, low jejunum and aboral ileum were 
halved longitudinally and the mucosa was scraped 
with an ampoule file. Half of the mucosal samples 
and one kidney were homogenized in 1% aqueous 
digitonin for UDP glucuronyltransferase determi- 
nations [ 18, 191 and the rest of mucosal samples 
together with the other samples in 0.25 M sucrose 
using a Potter Elvehjem homogenizer. From the 
9000g supernatant fraction of the liver homogenate 
a microsomal preparation was sedimented by centri- 
fuging at 105 OOOg for 60 min. The activity of aryl- 
hydrocarbon hydroxylase was determined from the 
sucrose homogenates of the mucosa and kidney and 
the liver microsomal preparation by using 3,4-benz- 
pyrene as substrate as described by Wattenberg et al. 
[7]. The determination of UDP glucuronyltrans- 
ferase activity was carried out on the digitonin homo- 
genates of the mucosa and kidney and the liver 
microsomal preparation in the presence of digitonin, 
with p-nitrophenol as the aglycone and 4.7 mmole/l 
concentration of UDP glucuronic acid [ 18, 191 at 
pH 7.0. 
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Fig. 1. The effect of intragastrjc ( o, 0) and intraperitonea1 (P, 4) administration of 3-nlettlyicholanthrene (open symbols) and 
3,4-benzpyrene (closed symbols) on the arylhydrocarbon hydroxylase activity of the rat in the duodenal mucosal homogenate 
(A), liver microsomes (B) and kidney homogenate (C). The triangles (A) represent the controls receiving olive oil intragastric~Iy. 
The standard errors of the means are indicated. 
3. Results 
The intragastric administration of a single dose 
of 3,4-benzpyrene or 3-methylcholanthrene caused 
an increase of both arylhydrocarbon hydroxylase 
and UDP ~ucuronyltransferase in the three tissues 
studied. The fastest response was observed in the 
hydroxylase activity of the intestinal mucosa 
(fig. IA). As early as 3 hr after the administration 
of 3,4-benzpyrene a significant increase had taken 
place. In the du~enum the maximal hydroxylase 
activity, 9- and 12-fold increase after 3,4benzpyrene 
and 3-methylcholanthrene administration, respective- 
ly, was observed in 9-12 hr. Also the decrease of 
enzyme activity to the control level was rapid. The 
UDP glucuronyltransferase activity increased in 
duodenal mucosa less and at considerably slower 
rate (fig. 2A). The maximal activity (about 2 times 
higher than in controls) was observed 24-27 hr 
after the administration of either drug. 
The response of both arylhydrocarbon hydroxyl- 
ase and UDP glucuronyltransferase activity was like 
that of the duodenum in the low jejunum and 
aborai ileum (not shown in the figure). The relative 
increase in hydroxylase activity was, however, much 
higher due to lower initial levels in the aboral gut. 
The vehicle, olive oil, used in the administration of 
carcinogens also caused a transient increase in the 
activity of both enzyme systems studied in the in- 
testinal mucosa. 
In the liver both carcinogens, after an intragastric 
administration, caused about a 3.5-fold increase in 
the microsomal arylhydrocarbon hydroxylase acti- 
vity (fig. IB). The maximum was reached in 24 hr. 
The enzyme activity increased and also diminished 
at a slower rate than in the intestinal mucosa. It was 
still significantly elevated 3 days after treatment. 
Little change could be observed in hepatic UDP 
glucuronyltransferase activity during the first 24 hr 
after the exposure to 3,4_benzpyrene, but during 
the second day a maximum, 2 times the control 
level, was observed. 3-Methylcholanthrene adminis- 
tration caused a somewhat faster, and also a greater 
increase in hepatic UDP glucuronyltransferase 
activity than did 3Pbenzpyrene (fig. 2B). Intra- 
gastric administration of olive oil had a negligible 
effect on hepatic drug metabolism. When the car- 
cinogens were administered intraperitoneally, a much 
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Fig. 2. The effect of intragastric 3-methylcho~nthrene (100 mg/kg in olive oil fo) and 3,4-benzpyrene (100 mg/kg in olive oil (0) 
and alive oil (A) on the UDP glucuronyltransferase activity of rat duodenal mucosai homogenate (A), liver microsomes (B) and 
kidney homogenate (C). ‘Ibe standard errors of the means are indicated. 
higher response in hepatic arylhydrocarbon hydroxyl. 
ase activity was observed. Two days after the injec- 
tion, the enzyme activity was 3 times higher than 
after administration of a similar amount intragastri- 
tally. In the kidney the time course of the changes 
in the arylhydrocarbon hydroxylase and UDP glu- 
curonyltransferase activity after intragastric ad- 
ministration of 3-metl~ylcholanthrene was inter- 
mediate between that in the duodenum and liver 
(fig. iC and 2C). The administration of 3,4-benz- 
pyrene caused an accumulation of fluorescent meta- 
bolites in the kidney, which hampered the determi- 
nation of arylhydrocarbon hydroxylase by using 
3$4-benzpyrene itself as substrate. 
4. Discussion 
The enhancement of arylhydrocarbon hydroxyl- 
ase preceeded the smaller and slower increase in the 
UDP glucuronyltransferase activity in the three tis- 
sues studied after the administration of either 3,4- 
benzpyrene or 3-methylcholanthrene. The hydroxyl- 
ase activity was already decreasing when the UDP 
glucuronyltransferase activity was still increasing. 
This suggests different control mechanisms in the 
regulation of the levels of these two functionally 
and topochemically related enzymes, Since the 
products of arylhydrocarbon hydroxylase are sub- 
strates of UDP ~ucuronyltransferase, the possibi- 
lity of a substrate induction of the last mentioned 
enzyme cannot be excluded. 
The rapid response in the levels of the drug meta- 
bolizing enzymes in the intestinal mucosa after an 
exposure to carcinogens resembles the reaction in 
lungs, where a measurable increase of arylhydrocar- 
bon hydroxylase can be detected as early as two 
hours after an exposure to cigarette smoke [9]. The 
capacity of intestinal mucosa to metabolize drugs 
reflects the composition of the diet (221. Also, olive 
Volume 24, number 3 FEBS LETTERS August 1972 
oil probably contains compounds which are potent 
inducers of drug metaboI~ing enzymes. Corn oil 
has been shown to lack such compounds [20]. The 
induced state of mucosal drug metabolism was 
rapidly normalized. This may at least partly be ex- 
plained by the rapid cell renewal 1231. In two days 
both mucosal cells are replaced by new ones and 
the hydroxylase activity is normalized. 
The mucosal metabolism of carcinogens is prob- 
ably of considerable importance, since an intragas- 
tric administration of either 3,4benzpyrene or 
3-methylcholanthrene caused only a 3.5fold in- 
crease of microsomal ary~hydrocarbon hydroxylase 
in the liver in contrast to the much higher increases 
described in the literature [8, 241 or obtained in 
the present study after an intraperitoneal injection 
of equivalent anlount of carcinogen. In the liver 
the induced state persists over the follow up period. 
Five days after an administration of carcinogens a 
significant enhancement of giucuronide synthesis 
can be detected in liver slices 1121. 
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